Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

Benutzer: Gast

Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Rugo, H. S.; Finn, R. S.; Diéras, V.; Ettl, J.; Lipatov, O.; Joy, A. A.; Harbeck, N.; Castrellon, A.; Iyer, S.; Lu, D. R.; Mori, A.; Gauthier, E. R.; Bartlett, C. Huang; Gelmon, K. A.; Slamon, D. J.
Titel:: Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
Zeitschriftentitel:: Breast Cancer Research and Treatment
Jahr:: 2019
Band / Volume:: 174
Heft / Issue:: 3
Seitenangaben Beitrag:: 719-729
Volltext / DOI:: doi:10.1007/s10549-018-05125-4
Verlag / Institution:: Springer Science and Business Media LLC
E-ISSN:: 0167-68061573-7217
Publikationsdatum:: 10.01.2019
BibTeX

Vorkommen: